JULIE GASTIER-FOSTER to Drug Resistance, Neoplasm
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Drug Resistance, Neoplasm.
Connection Strength
0.416
-
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia. Nat Cancer. 2020 11; 1(11):1113-1127.
Score: 0.132
-
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep. 2018 04 03; 23(1):255-269.e4.
Score: 0.111
-
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. Nature. 2018 01 25; 553(7689):511-514.
Score: 0.109
-
Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia. Cancer Discov. 2022 11 02; 12(11):2646-2665.
Score: 0.038
-
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2016 10 04; 113(40):11306-11311.
Score: 0.025